Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes

This study has been terminated.
(Research site no longer available)
Information provided by (Responsible Party):
Alan Zillich Lab, Purdue University Identifier:
First received: December 18, 2012
Last updated: August 26, 2015
Last verified: August 2015
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed

Condition Intervention
Medication Adherence
Blood Pressure
Device: Medication reminder

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: The Effect of Medication Reminder Technology on Medication Adherence and Hypertension

Further study details as provided by Purdue University:

Primary Outcome Measures:
  • self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • systolic blood pressure in mmHg using a valid automated device [ Time Frame: 6 months ]

Enrollment: 28
Study Start Date: June 2013
Study Completion Date: January 2015
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: medication reminder
medication reminder
Device: Medication reminder
Medication reminder
Placebo Comparator: Placebo


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • poor medication adherence
  • high blood pressure

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01755312

United States, Indiana
Purdue University
West Lafayette, Indiana, United States, 47906
Sponsors and Collaborators
Purdue University
  More Information

Responsible Party: Alan Zillich Lab, Associate Professor Pharmacy Practice, Purdue University Identifier: NCT01755312     History of Changes
Other Study ID Numbers: 2r44ago39178-02 (1208012596)
Study First Received: December 18, 2012
Last Updated: August 26, 2015

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases processed this record on May 24, 2017